Working Group on Antimicrobial Resistance
The OIE Working Group on Antimicrobial Resistance will:
1. Report to the OIE Director General, who will transmit the report, or relevant parts of it, to the appropriate OIE Specialist Commissions and the OIE World Assembly of Delegates.
2. Maintain a global perspective and foresight on antimicrobial resistance regarding animal health and the interface with human health, food production and the environment.
3. Assist the OIE Director General and OIE Specialist Commissions to identify risks and risk management options associated with antimicrobial resistance through development and maintenance of OIE International Standards (Terrestrial Animal Health Code, Aquatic Animal Health Code, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals and Manual of Diagnostic Tests for Aquatic Animals.
4. Identify and assist the OIE Director General in the development of additional guidance related to antimicrobial resistance to assist the interpretation and implementation of OIE International Standards.
5. Assist the OIE Director General, as requested, in the implementation of other aspects of the OIE Strategy on Antimicrobial Resistance and the Prudent use of Antimicrobials, in particular:
- a. the maintenance of the OIE collection of data intended for use of antimicrobial agents and its connection to the World Animal Health Information System and the Tripartite Integrated Surveillance System on AMR;
- b. the maintenance and further refinement of the OIE List of Antimicrobial Agents of Veterinary Importance and the follow up of its recommendations;
- c. the development and implementation of capacity development activities in OIE Member Countries related to antimicrobial resistance, including through the PVS Pathway, OIE Focal Point training, and e-learning platforms;
- d. the design and implementation of communication activities to raise awareness, improve understanding and create behavioural change;
- e. the conceptualisation, prioritisation, implementation and interpretation of research on antimicrobial resistance and alternatives to antimicrobials and its impacts on animal health, animal welfare and veterinary public health;
- f. the establishment of an information system on falsified and substandard drugs, and the development of work programme activities to manage associated risks;
- g. the support of the OIE and Member Countries in the development, implementation, interpretation and response to monitoring and evaluation activities.
6. Support the OIE in its Tripartite activities following the Global Action Plan and its role within the future secretariat in relation to the global governance mechanism that is to be established.
7. Address specific issues referred to the Working Group by the OIE Director General, which may include matters recommended by Specialist Commissions, Member Countries or the OIE itself.
8. Support the activities of OIE Collaborating Centres related to veterinary medicinal products and antimicrobial resistance and encourage the establishment and implementation of an effective network of expertise in support of the OIE and its Member Countries.
9. Support and advise the OIE in its interactions and collaborations with the broad network of animal and veterinary public health sector partners and stakeholders to achieve strong coordination on antimicrobial resistance within this community of interest.
Responsible: AMR-VP Department
|Dr Tomoko Ishibashi (Chair)Director, International Standards Office|
Food Safety Policy Division
Food Safety and Consumer Affairs Bureau
Ministry of Agriculture, Forestry and Fisheries
Government of Japan
Chiyoda-ku, Tokyo 100-8950
| Dr Gérard MoulinDirecteur de Recherches, adjoint au Directeur de l’ANMVOIE Collaborating Centre for Veterinary Medicinal ProductsAgence Nationale du Médicament VétérinaireAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail|
14 rue Claude Bourgelat
Parc d’Activités de la Grande Marche
Javené CS 70611
35306 Fougères Cedex
|Dr Donald Prater|
Associate Commissioner for Imported Food Safety
Office of Foods and Veterinary Medicine
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
UNITED STATES OF AMERICA[email protected]
|Prof. Moritz van VuurenEmeritus Professor in Microbiology|
Vice-Chair: Ministerial Advisory Committee on Antimicrobial Resistance
Postnet Suite 64
Private Bag X10
|Dr Fajer Al Salloom|
Vice-President of the OIE Regional Commission for the Middle East
Chief Pharmacy & Veterinary Diagnostic LabAnimal Control & Health Directorate
Ministry of Works, Municipalities Affairs and Urban Planning
|Dr Stephen PageDirector, Veterinary Clinical Pharmacology and Toxicology|
Advanced Veterinary Therapeutics
PO Box 905
Newtown NSW 2042
AUSTRALIA[email protected][email protected]
|Ms Barbara Freischem|
Head of Department
Surveillance and Regulatory Support
Veterinary Medicines Division
European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
|April 2021||Report of the Working Group on Antimicrobial Resistance||Report_Apr_2021|
|October 2020||Report of the Working Group on Antimicrobial Resistance||Report_Oct_2020|
|April 2020||Report of the Working Group on Antimicrobial Resistance||Report_Apr_2020|
|October 2019||Report of the Working Group on Antimicrobial Resistance||Report_Oct_2019|